In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Shire Pharmaceutical buys Pharmavene for $90.5mm

Executive Summary

UK bone and CNS pharmaceutical company Shire Pharmaceuticals bought US drug delivery company Pharmavene, (which will become Shire Laboratories) in an earnout. Shire Pharma will initially pay $90.5mm (UK55.5mm)--$25mm in cash and the rest in stock.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
    • Drug Delivery
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Includes Earnout
    • Payment Includes Cash
    • Payment Includes Stock

Related Companies